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Abstract
Loss-of-function mutations of the KRIT1 gene (CCM1) have been associated with the Cerebral Cavernous Malformation
(CCM) disease, which is characterized by serious alterations of brain capillary architecture. The KRIT1 protein contains
multiple interaction domains and motifs, suggesting that it might act as a scaffold for the assembly of functional protein
complexes involved in signaling networks. In previous work, we defined structure-function relationships underlying KRIT1
intramolecular and intermolecular interactions and nucleocytoplasmic shuttling, and found that KRIT1 plays an important
role in molecular mechanisms involved in the maintenance of the intracellular Reactive Oxygen Species (ROS) homeostasis
to prevent oxidative cellular damage. Here we report the identification of the Kelch family protein Nd1-L as a novel
molecular interactor of KRIT1. This interaction was discovered through yeast two-hybrid screening of a mouse embryo cDNA
library, and confirmed by pull-down and co-immunoprecipitation assays of recombinant proteins, as well as by co-
immunoprecipitation of endogenous proteins in human endothelial cells. Furthermore, using distinct KRIT1 isoforms and
mutants, we defined the role of KRIT1 domains in the Nd1-L/KRIT1 interaction. Finally, functional assays showed that Nd1-L
may contribute to the regulation of KRIT1 nucleocytoplasmic shuttling and cooperate with KRIT1 in modulating the
expression levels of the antioxidant protein SOD2, opening a novel avenue for future mechanistic studies. The identification
of Nd1-L as a novel KRIT1 interacting protein provides a novel piece of the molecular puzzle involving KRIT1 and suggests a
potential functional cooperation in cellular responses to oxidative stress, thus expanding the framework of molecular
complexes and mechanisms that may underlie the pathogenesis of CCM disease.
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Introduction
KRIT1 is a gene responsible for Cerebral Cavernous Malfor-
mations (CCM), a major cerebrovascular disease, with a preva-
lence of 0.1%–0.5% in the general population, characterized by
abnormal vascular sinusoids that predispose to seizures, focal
neurological deficits, and fatal intracerebral hemorrhage [1,2,3,4].
Comprehensive analysis of the KRIT1 gene in CCM patients has
suggested that KRIT1 functions need to be severely impaired for
pathogenesis [5,6,7]. On the other hand, the targeted disruption of
KRIT1 gene in animal models has resulted in lethal vascular
defects early in embryogenesis, pointing to a major role for the
KRIT1 protein in blood vessel formation/stabilization [8]. In
addition, our recent data demonstrate that KRIT1 plays an
important role in molecular mechanisms involved in the mainte-
nance of the intracellular Reactive Oxygen Species (ROS)
homeostasis to prevent oxidative cellular damage, suggesting a
novel mechanism for CCM pathogenesis [9].
Nevertheless, the physio-pathological role of KRIT1 is still
elusive and remains a fundamental research challenge for
understanding the molecular bases of the CCM pathogenesis.
KRIT1 lacks defined catalytic domains while contains well
characterized protein-protein interaction motifs and domains,
including three NPXY/F motifs, three ankyrin repeats and a
FERM domain, indicating a possible function as scaffold protein
for organizing protein complexes involved in signaling networks
[10,11,12,13,14,15,16].
The primary insight into KRIT1 function came from its original
isolation in a yeast two-hybrid (Y2H) screening as a binding
partner of the small GTPase Rap1 [12], a Ras family member
involved in fundamental physiological processes through the
regulation of cadherin- and integrin-dependent cell adhesion and
signaling [17,18]. Specifically, the interaction with Rap1 has been
shown to occur at the KRIT1 C-terminal FERM domain, a
clover-shaped structural module formed by three subdomains (F1,
F2 and F3) which is known to mediate intermolecular interactions
with partner proteins and phospholipids as well as intramolecular
regulatory interactions [19]. Indeed, subsequent researches
demonstrated that the interaction of KRIT1 with Rap1 plays an
important role in stabilization of endothelial cell-cell junctions and
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regulation of cell-cell adhesion processes in both endothelial and
non-endothelial tissues [20,21].
Additional clues to the function of KRIT1 have been provided
by the demonstration of other molecular interactions mediated by
distinct domains of the protein.
In particular, a NPXY motif located in the N-terminal region of
KRIT1 (aa 1–207) is required for the interaction with ICAP1, a
PhosphoTyrosine-Binding (PTB) domain-containing protein pre-
viously characterized as interactor and regulator of b1 integrin,
suggesting that KRIT1 may regulate the ICAP1 regulatory effect
on b1 integrin [13,15].
Two additional NPXY/F motifs located in the central region of
KRIT1 (aa 208–417) have been demonstrated to be required for
KRIT1 interaction with CCM2 [14,16], and subsequently it has
been shown that through this interaction KRIT1 regulates
vascular permeability by suppressing the RhoA-ROCK signaling
pathway, strongly dysregulated in human CCM endothelium
[22,23]. Furthermore, we recently demonstrated that the region
containing the second and third NPXY/F motifs is involved in a
head-to-tail intramolecular interaction with the PTB-like F3
subdomain of the C-terminal FERM domain and suggested a
model where KRIT1A behaves as a molecular switch and
regulates its function by adopting different open/closed confor-
mations. This open/closed conformation switch mediates mutually
exclusive effects on KRIT1A nuclear translocation and molecular
interactions [11].
On the other hand, we previously identified a second KRIT1
isoform, KRIT1B, characterized by the alternative splicing of the
15th coding exon, which results in a shorter protein lacking 39 aa
in the C-terminus [24]. We found that the alternative splicing
strongly affects the structure of the F3/PTB lobe of the KRIT1
FERM domain with important functional implications, including
the loss of the ability to undertake head-to-tail intramolecular
interaction, binding to Rap1 and nucleocytoplasmic shuttling.
KRIT1 also contains three ankyrin repeats located between the
NPXY/F motifs and the FERM domain. Although ankyrin
repeats are found in a multitude of proteins of diverse functions
and are known to mediate protein-protein interactions [25], no
binding proteins for the KRIT1 ankyrin repeats have been
identified so far.
The presence of distinct binding motifs and domains strongly
indicates that KRIT1 can interact with multiple protein partners
to regulate complex signaling pathways, suggesting that the
identification of novel molecular interactors may represent a
crucial step in elucidating its function.
To further define KRIT1 molecular and cellular functions and
provide novel insights for a better understanding of CCM
pathogenesis mechanisms, we attempted to find new KRIT1
interaction partners using a Y2H screening approach. Here we
report the identification and characterization of a novel KRIT1
molecular interaction with Nd1-L, a member of the BTB/Kelch
protein family.
Results
Identification of Nd1 as a novel interaction partner of
KRIT1
In order to identify new binding partners of KRIT1 we used the
GAL4BD-K272NT fusion construct, encoding the N-terminal 272
aa fragment of KRIT1 fused to the GAL4 DNA binding domain,
as bait for the Y2H screening of a mouse embryo cDNA library.
Twenty-two clones positive by HIS3, ADE2, MEL1 and LACZ
expression were initially isolated out of 8.86107 independent
clones. The pACT2 plasmids containing the cDNA sequence of
putative KRIT1 interaction partners were recovered from the
yeast cells and then used in a small scale two hybrid assay to verify
the specific interaction with KRIT1. Among the 22 isolated
clones, 5 exhibited a K272NT-dependent HIS3/ADE2-positive
genotype upon retransformation. DNA sequencing and Genebank
database search revealed that one of these five clones, named C17
(Fig. 1A), encoded a 147-amino acid polypeptide corresponding to
the C-terminal portion (aa 496–642) of the Nd1-L protein
(NP_001034601.1) (Fig. 1B) [26]. This is a member of the Kelch
family proteins and is characterized by a BTB/POZ domain in its
N-terminus (aa 1–128) followed by a BACK domain (aa 134–233)
and six canonical kelch repeat motifs at the C-terminus.
The Nd1-L fragment encoded by the C17 clone (Nd1-L 496–
642) is devoid of the BTB/POZ and BACK domains, containing
only a portion of the kelch repeats comprised from the C-terminal
portion of the third to the sixth motif (Fig. 1C).
Nd1-L interacts with KRIT1 both in vitro and in
endothelial cells
To confirm the novel interaction identified by the Y2H analysis,
a GST pull-down assay of whole-cell extracts from HEK293 cells
overexpressing GFP-K272NT or GFP-KRIT1A was performed
using a GST-Nd1-L (496–642) fusion protein as a bait. GST-
bound fractions were subjected to western blot analysis with anti-
GFP antibody. As shown in Fig. 2A, both K272NT and KRIT1A
were specifically detected only in the GST-Nd1-L-bound fractions.
Thus, consistently with the two-hybrid outcomes, the GST pull-
down assay showed that the Nd1-L (496–642) polypeptide
encoded by the C17 clone was able to interact with the N-
terminal K272NT fragment in vitro. In addition, Nd1-L (496–642)
interacted also with full-length KRIT1A.
A further pull-down experiment was performed using GST-
KRIT1A as bait and a lysate of HEK293 cells overexpressing
FLAG-Nd1-L as prey. As shown in Fig. 2B, full-length Nd1-L
maintained the capability to interact with KRIT1A in vitro.
Control pull-down assays of cell lysates overexpressing the GFP
or the FLAG tags was performed to assess the specificity of the
interaction between KRIT1 and Nd1.
In order to demonstrate the interaction between KRIT1A and
Nd1-L in vivo, we performed co-IP of the two endogenous proteins
from human cells. As shown in Fig. 3, endogenous Nd1-L and
KRIT1 co-immunoprecipitated from HUVEC cell lysates assayed
with an anti-KRIT1 antibody. These results confirmed and
extended Y2H and GST pull-down outcomes, demonstrating that
the interaction between endogenous KRIT1 and Nd1-L proteins
occurs in human endothelial cells.
Mapping of the KRIT1/Nd1-L interaction
In a previous work we identified a novel KRIT1 isoform,
KRIT1B, characterized by the alternative splicing of the 15th
coding exon, which results in a 117-bp in-frame deletion
accounting for the exclusion of 39 aa in a region close to C-
terminus of full-length KRIT1A [24]. The alternative splicing
affects the b sandwich of the F3/PTB lobe of the KRIT1 FERM
domain. This significant structural impact has important func-
tional implications as it regulates crucial functions of KRIT1,
including its head-to-tail intramolecular interaction and nucleo-
cytoplasmic shuttling, Rap1 binding, and modulation of ICAP1
nucleocytoplasmic trafficking [11].
To evaluate whether an intact KRIT1 FERM domain was
required for the interaction with ND1-L, we used HEK293 cells
overexpressing both FLAG-Nd1-L and GFP-KRIT1A or GFP-
KRIT1B to perform a co-IP assay. Cell lysates were incubated
with the anti-KRIT1 antibody to immunoprecipitate KRIT1-
Nd1-L Is a Novel Molecular Interactor of KRIT1
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containing complexes and then analyzed by western blotting with
an anti-FLAG antibody (Fig. 4A, upper panel). The IP of GFP-
KRIT1A and GFP-KRIT1B was verified by probing western blots
with the anti-GFP antibody (Fig. 4A, lower panel). Only KRIT1A,
but not KRIT1B, was able to co-immunoprecipitate Nd1-L,
clearly indicating that an intact FERM domain is required for the
interaction of full length KRIT1 with Nd1-L.
In order to further define the involvement of the KRIT1A
FERM domain in the interaction with Nd1-L, we performed a
GST pull-down assay by probing HEK293 cell lysates overex-
pressing FLAG-Nd1-L with the FERM domain of KRIT1A and
KRIT1B fused to GST (GST-K1AFERM and GST-K1BFERM,
respectively).
GST-KRIT1A and GST-K272NT were introduced in the assay
as positive controls. As shown in Fig. 4B, K1AFERM, but not
K1BFERM, was able to interact with Nd1-L in the pull-down
assay, indicating that the KRIT1A FERM domain is involved in
the interaction with Nd1-L, and further supporting the finding that
the integrity of the FERM domain is required for the interaction.
To better determine the contribution of the different KRIT1
domains to the interaction with Nd1-L, we assayed the ability of
different regions of KRIT1 to bind full-length Nd1-L by using a
small scale Y2H assay. AH109 yeast strain was co-transformed
with a GAL4AD fusion construct encoding full-length Nd1-L and
GAL4DNABD fusion constructs encoding different fragments of
KRIT1A and KRIT1B isoforms (Fig. 5A). Yeast cells co-
transformed with the two pGBKT7 and pGADT7 empty vectors
were used in the Y2H experiment as negative controls to exclude
any intrinsic basal transcriptional activity of the proteins used in
the assay, while the interaction between SV40 large T antigen
(SV40-T) and p53 was used as positive control [27]. Preliminary
control co-transformations with appropriate combinations of
empty vectors (pGBKT7 or pGADT7) and pGBKT7(BD)/
KRIT1 or pGADT7(AD)/Nd1-L constructs, as well as Western
blotting analysis of GAL4BD and GAL4AD fusion protein
Figure 1. Identification of Nd1-L as a new interaction partner of KRIT1. A. Small scale yeast two-hybrid analysis of the interaction of KRIT1
with the C17 clone. Yeast strain AH109 was cotransformed with GAL4DNA-BD and GAL4AD fusion constructs as indicated (left). Cotransformed
AH109 cells were streaked out on plates lacking tryptophan and leucine (SD/-Trp/-Leu) or plates lacking tryptophan, leucine, histidine and adenine
(SD/-Trp/-Leu/-His/-Ade). The known interaction between p53 protein and SV40 large T-antigen was used as positive control. Empty vectors encoding
the GAL4DNA-BD and AD were used as negative control and to exclude aspecific interactions of both K272NT and C17. B. Amino acid sequence of
Nd1-L (NP_001034601.1). The sequence of C17 corresponding to Nd1-L (496–642) is underlined. C. Domain structure of the Nd1-L protein. The
fragment identified as K272NT interactor in the yeast two-hybrid assay, Nd1-L (496–642), contains a portion of the kelch domain extending from the
C-terminal portion of the third to the sixth kelch repeat motif.
doi:10.1371/journal.pone.0044705.g001
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expression in transformed yeast extracts were also performed, and
not shown for simplicity. Protein-protein interactions were assayed
on the basis of the ability of transformants to grow in minimal
medium lacking His and Ade (activation of HIS3 and ADE2
reporter genes) (Fig. 5B). Activation of the LacZ reporter gene was
afterwards assayed by determining b-galactosidase activity of His+
trasformants using a filter assay.
The outcomes of these experiments are summarized in Fig. 5C.
Consistently with previous results, full-length KRIT1A and the
two fragments K272NT and K1AFERM, but not full-length
KRIT1B and K1BFERM, were able to interact with Nd1-L in
yeast cells. The KRIT1A fragment lacking the N-terminal 207
amino acids (K1AD207) maintained the capability to bind Nd1-L,
while the corresponding K1BD207 fragment was devoid of this
capacity. The N-terminal 207aa fragment (K207NT) did not
interact with Nd1-L as well.
These data indicate that the first 207 amino acids of KRIT1 are
not sufficient for the interaction of K272NT with Nd1-L, and
suggest that the region 207–272 is necessary for the interaction,
but not sufficient if the C-terminal portion of the protein contains
an altered FERM domain.
Nd1-L overexpression induces KRIT1 nucleus-to-
cytoplasm translocation
As a first step in understanding the functional significance of the
molecular interaction between Nd1-L and KRIT1, we examined
the subcellular distribution of the two proteins expressed
transiently in COS and A7r5 cells as fusion proteins with the C-
terminus of FLAG and GFP tags, respectively. Both COS and
A7r5 cells have abundant cytoplasm and hence allow easy
assessment of subcellular localization.
As compared with the single-expressed GFP-KRIT1A and
FLAG-Nd1-L proteins, having respectively a predominantly
nuclear (Fig. 6 A,D) and a prevalently cytoplasmic (Fig. 6 B,E)
subcellular distribution, the co-expression of FLAG-Nd1-L and
GFP-KRIT1A resulted in a reduced nuclear accumulation of
GFP-KRIT1A and a significant cytoplasmic co-localization of the
two proteins (Fig. 6 C,F), indicating that Nd1-L may influence the
subcellular distribution of KRIT1.
Nd1-L may cooperate with KRIT1 in modulating the
expression levels of SOD2
To explore further the potential functional relationship between
Nd1-L and KRIT1, we took advantage of KRIT1-null and
KRIT1-expressing MEF cells previously obtained and character-
ized in our laboratory [9]. In particular, using these cellular
Figure 2. The Nd1-L protein interacts with KRIT1A in vitro. A. HEK293 cells were transiently transfected with pEGFP vector containing K272NT
(left panel) or full-length KRIT1A (right panel). The pull-down assay was performed by incubating transfected (GFP-K272NT, GFP-KRIT1A) or mock-
transfected (CTRL) cell lysates with GST-Nd1-L (496–642) immobilized on glutathione-sepharose resin, as indicated. Incubation of transfected cell
lysates with GST-glutathione-sepharose was used as negative control. The different incubation mixtures were then analyzed by SDS-PAGE and
western blotting with anti-GFP together with aliquots of transfected and mock-transfected cell lysates as controls. B. HEK293 cells were transiently
transfected with 2FLAG-Nd1-L. Lysates from transfected (FLAG-Nd1-L) or mock-transfected (CTRL) cells were then incubated with GST-KRIT1A-
glutathione-sepharose or with GST-glutathione-sepharose, as indicated. The different incubation mixtures and aliquots of transfected and mock-
transfected cells were analyzed by SDS-PAGE and western blotting with anti-FLAG antibodies.
doi:10.1371/journal.pone.0044705.g002
Figure 3. Nd1-L and KRIT1 associate in HUVEC cells. Lysates from
HUVEC cells were immunoprecipitated with anti-KRIT1 polyclonal
antibody or an unrelated antibody as negative control followed by
SDS-PAGE and western blotting with an anti-Nd1 antibody (upper
panel). Immunoreactive bands at 50 kDa indicate IgG-heavy chains. The
IP of KRIT1 was verified by blotting against KRIT1 (lower panel). An
aliquot of the HUVEC cells lysate was loaded in the same gel as positive
control for the immunodetection phase and to evaluate the relative
expression levels of KRIT1 and Nd1.
doi:10.1371/journal.pone.0044705.g003
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models we previously showed that KRIT1 plays a role in
regulating the expression level of the antioxidant enzyme SOD2
[9]. To assess whether Nd1-L was able to affect this KRIT1
function, SOD2 expression levels were analyzed by western
blotting in KRIT1-null (Krit1-) and KRIT1-expressing (Krit1+)
MEF cells upon transient transfection with Flag-Nd1-L cDNA.
Remarkably, as compared with KRIT1-null MEF cells where
SOD2 protein levels were not influenced by the expression of
FLAG-Nd1-L (Fig. 7, lanes 1 and 2), KRIT1-expressing MEF cells
showed enhanced SOD2 levels in the presence of FLAG-Nd1-L
(Fig. 7, lanes 3 and 4), suggesting a potential cooperation between
Nd1-L and KRIT1 in regulating SOD2 expression, and opening a
novel perspective for future mechanistic studies on the functional
significance of the newly identified molecular interaction.
Discussion
To date, the physiological function of KRIT1 is still elusive and
remains a fundamental research challenge for understanding the
molecular mechanisms of CCM pathogenesis. The presence in the
protein of well characterized motifs and structural domains as well
as its known molecular interactions [12,13,14,15,16] suggest that
KRIT1 might act as a scaffold for the assembly of functional
protein complexes involved in physiologically important signaling
networks, including the crosstalk between cell adhesion receptors
and the cytoskeleton [18].
In this study we describe the identification of the Kelch family
member Nd1-L as a novel KRIT1 interacting partner.
The Nd1 gene was originally isolated in murine cells and tissues
as a housekeeping gene coding a cytosolic, actin-binding protein
involved in the dynamic organization of the actin cytoskeleton
[26,28]. Further studies performed in transgenic mice indicated
that the Nd1-L protein plays a protective role against cytoskeletal
stress induced by doxorubicin treatment and may protect cells
against oxidative stress [29,30]. Moreover, a recent paper showed
that this protein is able to negatively regulate Rho family GTPase
activation, which may result in suppression of invasion and
migration activity in cancer cells, thus pointing to an important
functional connection between Nd1-L and Rho family proteins
[31].
The human orthologue of Nd1-L, NS1-BP, has been isolated as
an interactor of the nonstructural NS1 protein of the influenza A
virus [32]. Although this protein has been originally shown to have
a primary nuclear localization, further evidence demonstrated that
also NS1-BP is able to associate with actin filaments [33].
Nd1-L contains a BTB/POZ domain in its N-terminus and six
kelch repeats in the C-terminus [26]. The kelch motif appears in
many different polypeptide contexts and contains multiple
potential protein-protein contact sites. Members of the kelch
repeat superfamily are present throughout the cell and extracel-
lularly and have diverse activities [34]. Many kelch domain
containing proteins, including Nd1-L, interact with actin and have
been demonstrated to be important mediators of fundamental
cellular functions, such as regulation of cellular architecture,
cellular organization, and cell migration [26,34]. In addition to the
kelch motifs, Nd1-L, like the majority of the kelch proteins,
contains a BTB/POZ (broad complex, tramtrack and brick a
brac/Pox virus and zinc finger) domain that mediate protein-
protein interactions [35,36], and a BACK (BTB and C-terminal
Kelch) domain that is thought to play a role in molecular
orientation processes preliminary to protein complex formation
[36].
The novel interaction between KRIT1 and Nd1-L has been
identified through a Y2H screening of a mouse embryo cDNA
library using the N-terminal 272 aa fragment of KRIT1 as bait.
Specifically, the mouse Nd1-L cDNA isolated by the Y2H
screening encoded a C-terminal 147-amino acid fragment of
Figure 4. The integrity of the KRIT1 FERM domain is required for the interaction with Nd1-L. A. KRIT1A but not KRIT1B is able to interact
with Nd1-L. HEK293 cells were co-transfected with pCR-2FLAG-Nd1-L and pEGFP-KRIT1A or pEGFP-KRIT1B constructs as indicated. 36 hours after co-
transfections the cells were harvested and lysed as detailed in Materials and Methods. The co-IP was performed by incubation with anti-KRIT1 or an
unrelated antibody as negative control, followed by SDS-PAGE analysis and western blotting with anti-FLAG (upper panel). Mock-transfected cells
were used in the assay as controls (CTRL). The IP of EGFP-KRIT1A or EGFP-KRIT1B was verified by anti-GFP western blot (lower panel). Lysates from
both transfected and mock-transfected HEK293 cells were loaded in the same gels as positive and negative controls for the immunodetection phase.
B. Two different regions of KRIT1 are involved in the interaction with Nd1-L. Full-length KRIT1A, K1AFERM, K1BFERM and K272NT were expressed as
GST-fusion proteins and ligated to glutathione-sepharose. Lysates from HEK293 cells overexpressing 2FLAG-Nd1-L were incubated with the different
affinity resins as indicated. Incubation with GST-glutathione-sepharose was used as negative control. The different incubation mixtures and an aliquot
of the transfected cell lysate were analyzed by SDS-PAGE and anti-FLAG western blotting.
doi:10.1371/journal.pone.0044705.g004
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Figure 5. The interaction with Nd1-L involves two different regions of KRIT1. A. Schematic representation of the KRIT1 isoforms and
deletion mutants used in the assay. B. Yeast two-hybrid analysis of the KRIT1-Nd1-L interaction. pGADT7-Nd1-L was used to co-transform AH109
yeast strain along with different fragments of KRIT1A and KRIT1B isoforms cloned in pGBKT7, as summarized in the associated table (C). Co-
transformants were selected on minimal medium lacking Trp and Leu. Protein-protein interaction was assayed on the basis of the ability of Trp+Leu+
transformants to grow in minimal medium lacking His and Ade (activation of HIS3 and ADE2 reporter genes). Yeast cells co-transformed with the
pGBKT7 and pGADT7 empty vectors were used as negative control. The interaction between SV40 large T antigen (SV40-T) and p53 was used as
positive control. The results of the determination of b-galactosidase activity of Trp+Leu+His+ colonies by filter assay are shown in C. ++++ indicates
Nd1-L Is a Novel Molecular Interactor of KRIT1
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Nd1-L (from 496 to 642 aa residues) containing a portion of the
kelch domain extending from the C-terminal portion of the third
to the sixth kelch repeat motif, suggesting that this region contains
the binding site for KRIT1.
The physical interaction of both the C-terminal fragment and
full-length Nd1-L with KRIT1 was afterwards demonstrated using
an in vitro GST pull-down assays, while co-IP experiments
unequivocally demonstrated the association of Nd1-L and KRIT1
endogenous proteins in human endothelial cells.
Furthermore, using KRIT1A and KRIT1B isoforms and
distinct KRIT1 mutated constructs we defined the contribution
of the different KRIT1 domains to the KRIT1/Nd1-L interaction.
We demonstrated that the KRIT1B isoform, bearing an incom-
plete F3/PTB FERM subdomain, is not able to bind Nd1-L, as
well as that the interaction involves both N-terminal and C-
terminal regions of KRIT1A.
The 272 aa N-terminal fragment of KRIT1 used as bait in the
initial two-hybrid screening contains a NPXY motif required for
KRIT1 interaction with ICAP1 [13,15] and two additional
NPXY/F motifs required for the interaction with CCM2
[14,16]. In addition, the region containing the second and third
NPXY/F motifs has been demonstrated to be involved in the
intramolecular interaction with the PTB-like subdomain of the C-
terminal FERM domain, playing a pivotal regulatory role in the
control of the KRIT1A open/closed conformation switch and
nucleocytoplasmic shuttling [11]. Our Y2H data indicate that the
region 207–272, containing the second and third NPXY/F motifs,
is necessary for the interaction with Nd1-L. However, in the full
length KRIT1 protein this region is not sufficient for the
interaction in the absence of an intact FERM domain, thus
strengthening the active involvement of the F3/PTB FERM
subdomain and consistenting with a bipartite interaction model.
Accordingly, the bipartite mode of interaction between KRIT1
and Nd1-L is reminiscent of the well characterized bipartite
interaction between the FERM domain containing adaptor
protein Talin and integrin b-subunit cytoplasmic tails [37,38],
which plays a major role in regulating integrin affinity for
extracellular ligands [39,40] and coupling to the actin cytoskeleton
[41,42]. Indeed, both the N-terminal FERM and the C-terminal
rod domains of Talin have been found to interact with the
cytoplasmic tail of integrin b-subunits. Specifically, the F3/PTB-
like subdomain of the Talin FERM domain binds to a canonical
NPXY motif at the membrane-proximal region of the integrin b-
subunit cytoplasmic tail, whereas the integrin-binding site located
in the Talin rod domain (IBS2) binds to a more distal region [37].
Interestingly, Talin may also undergo an autoinhibitory intramo-
lecular interaction involving its N- and C-terminal portions
whereby binding sites for interactors are masked. Remarkably,
this molecular behavior is common to most FERM proteins,
including KRIT1 [11].
Taken together with these analogies, our results point to a
model where both the N- and C-terminal portions of KRIT1 are
involved in the molecular interaction with Nd1-L, which in turn
may contribute to maintaining the KRIT1 open conformation
blue staining of colonies detected within 3 h; +++ blue staining after 4 h; ++ blue staining after 4,5 h; + blue staining after 5,5 h; – no blue staining
after 12 h. The results are representative of three independent experiments.
doi:10.1371/journal.pone.0044705.g005
Figure 6. Nd1-L influences the subcellular localization of KRIT1. Confocal microscopy analysis of COS-7 (A–C) and A7r5 (D–F) cells transiently
transfected with EGFP-KRIT1A (A,D) and Flag-Nd1 (B,E), or both (C,F) cDNA constructs. Nuclei and Flag-Nd1 were visualized with the Hoechst dye and
anti-Flag antibody coupled to Alexa FluorH 633 secondary antibody, respectively. Notice that GFP-KRIT1A is mainly localized into the nucleus when
expressed alone (A,D), while it accumulates into the cytoplasm upon co-expression with Flag-Nd1 (C,F). Within the cytoplasm, a significant co-
localization of the GFP-KRIT1A and Flag-Nd1-L proteins is also evident. Scale bar represents 15 mm.
doi:10.1371/journal.pone.0044705.g006
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required for its shuttling between nucleus and cytoplasm and
functioning as a scaffolding protein [11]. The bipartite mode of
interaction between KRIT1 and Nd1-L might in fact compete
with the KRIT1 autoinhibitory intramolecular interaction be-
tween the N- and C-terminal regions leading to KRIT1
cytoplasmic localization, which is in turn required for interaction
with Rap1.
Consistently, fluorescence microscopy experiments indicated
that Nd1-L contributes to the regulation of KRIT1 nucleocyto-
plasmic shuttling, thus providing a first evidence of the functional
significance of the KRIT1A/Nd1-L interaction. In addition,
molecular assays showed that Nd1-L might support KRIT1 in
regulating the expression levels of the ROS-scavenging enzyme
SOD2, suggesting a potential important functional cooperation in
cellular protection from oxidative stress that deserves further
exploration and mechanistic studies.
Thus, while showing the identification and characterization of
the novel molecular interaction between KRIT1 and Nd1-L, our
findings provide a promising framework for better understanding
of KRIT1 physiopathological functions and addressing molecular
mechanisms involved in CCM disease pathogenesis.
Materials and Methods
Plasmid construction
Full-length KRIT1A and KRIT1B, the K207NT (residues 1–
207) and K272NT (residues 1–272) KRIT1 N-terminal fragments,
the N-terminal truncated portion of KRIT1A (K1AD207; 208–
736) and KRIT1B (K1BD207; 208–697) were cloned as EcoRI/
SalI inserts into pGBKT7 (TRP1, Kanr) (Clontech) in frame with
the GAL4DNA-binding-domain (GAL4BD).
The constructs pGBKT7-K1AFERM and pGBKT7-
K1BFERM, containing the FERM domain of KRIT1A (418–
736) and KRIT1B (418–697) respectively, were prepared as
previously described [11].
The expression plasmid pCR-2FLAG-Nd1-L, containing mu-
rine full-length Nd1-L cDNA, was kindly provided by Dr. M.
Hatano, Chiba University, Japan [26].
Full length Nd1-L was obtained from pCR-2FLAG-Nd1-L by
enzymatic digestion and cloned as EcoRI/EcoRI insert into
pGADT7 (LEU2, Ampr) (Clontech) vector in frame with the GAL4
Activation Domain (GAL4AD).
To generate GST-fusion proteins, full length KRIT1A,
K1AFERM, K1BFERM and K272NT were cloned as EcoRI/
XhoI inserts in the pGEX-4T1 vector. The expression construct
encoding GST-tagged Nd1-L (496–642) was produced by EcoRI/
XhoI digesting the pACT2 construct isolated by two-hybrid
screening and then cloning the insert into the pGEX-4T2 vector.
Plasmid expression constructs encoding EGFP-tagged KRIT1A
and KRIT1B used for cell transfection experiments were prepared
as previously described [11].
The EGFP-tagged construct encoding K272NT was produced
by cloning the corresponding cDNA into the EcoRI/SalI sites of
pEGFP-C2 vector.
All constructed plasmids were verified by sequencing.
Yeast two-hybrid analysis
For Y2H experiments, all vectors, yeast strains, reagents and
methods were derived from the GAL4 based MATCHMAKER
Two-hybrid system 3 (Clontech).
The expression of GAL4BD and GAL4AD fusion proteins used
in Y2H experiments was verified by Western blotting analysis of
transformed yeast protein extracts with anti-GAL4-DNA-BD or
anti-HA epitope mAbs respectively.
For initial screening, the K272NT fragment fused with
GAL4BD in the pGBKT7 vector was used as bait and
transformed into AH109 (MATa) yeast strain, which was then
mated with Y187 (MATa) yeast strain pre-transformed with a
mouse embryo cDNA library fused with GAL4AD in the pACT2
vector. Diploid cells, containing the reporter genes HIS3, ADE2,
MEL1 and LACZ, were plated on selective medium. The clones
resulting positive by the 4 reporter genes expression were
candidates for harboring interacting hybrid proteins. The pACT
vectors carrying potential positive interacting cDNAs were rescued
from yeast cells and reintroduced into pGBKT7-K272NT- or
pGBKT7-containing AH109 cells to verify the specific interaction
between bait and prey proteins. Those cDNAs that exhibited a
K272NT-dependent HIS3/ADE2-positive genotype upon retrans-
formation were sequenced by using a GAL4AD sequencing primer
and compared with known sequences in GenBank. The sequence
of clone C17, studied in this work, was aligned with the nucleotide
sequence NM_001039512.
For small-scale assays, pGBKT7 and pGADT7 constructs were
cotransformed into AH109 cells and cotransformants were than
selected on minimal medium lacking Trp and Leu. Protein-protein
interactions were assayed on the basis of the ability of transfor-
mants to activate HIS3, ADE2 and LACZ reporter genes. AH109
cells cotrasformed with pGBKT7-53, encoding a GAL4DNA-BD
fusion with the murine p53 protein, and pTD1, encoding a
GAL4AD fusion with the SV40 large T antigen, were used as
positive controls, whereas yeast cells cotransformed with empty
pGBKT7 and pGADT7 vectors were used as negative controls.
To evaluate the b-galactosidase activity of transformants a
colony lift filter assay was performed by following the manufac-
turer instructions (Clontech). Briefly, transformants were grown on
selective plates lacking Trp, Leu and His for 4–5 days;
Trp+Leu+His+ colonies were transferred onto Wathman 3MM
paper and immersed in liquid nitrogen for 20 sec. The filters were
thawed at room temperature, overlaid with Z buffer/X-gal
solution (PBS buffer, pH 7.0, 0.27% (v/v) b-mercaptoethanol,
0.03% (w/v) X-gal), incubated at room temperature and checked
periodically for the appearance of blue colonies.
Figure 7. Nd1-L may cooperate with KRIT1 in modulating the
expression levels of SOD2. KRIT1-null (Krit1-) and KRIT1-expressing
(Krit1+) MEF cells grown under standard conditions were either mock
transfected (2) or transfected with Flag-Nd1-L cDNA (+), and cell lysates
were analyzed by Western blot. The expression levels of Flag-Nd1-L
were assessed with an antibody against the Flag tag, whereas SOD2
and KRIT1 were detected with specific monoclonal and polyclonal
antibodies, respectively. Tubulin served as loading control. Notice that
the expression of Flag-Nd1-L induces an upregulation of SOD2 protein
levels in KRIT1-expressing but not KRIT1-null MEF cells.
doi:10.1371/journal.pone.0044705.g007
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Expression and purification of GST-fusion proteins
The different GST-tagged proteins were expressed and purified
by using the GST Gene Fusion System (GE Healthcare).
Induction was performed by incubating transformed E.coli BL21
cells at 18–30uC with IPTG (0.1–0.2 mM). GST fusion proteins
were finally analyzed by western blotting with anti-GST antibody
(GE Healthcare). The amount of expressed proteins was deter-
mined by using the Bradford method [43].
Cell culture and transient transfections
The following cell lines were used: HEK293 human embryonic
kidney cells and COS-7 monkey kidney fibroblast cells, purchased
from LG Standards-ATCC, UK (CRL-1573 and CRL-1651
respectively); A7r5 rat vascular smooth muscle cells, purchased
from Sigma-Aldrich, Italy (8605803); KRIT12/2 MEFs (K2/2)
and KRIT12/2 MEFs re-expressing KRIT1 (K9/6), described
previously [9].
All these cell lines were cultured at 37uC and 5% CO2 in
DMEM supplemented with 10% FBS, 1% penicillin/streptomy-
cin, 2 mM glutamine (only COS-7 and A7r5 cells). All media and
supplements for cell culture were from Gibco Life Technologies.
Human Umbilical Vein Endothelial Cells (HUVECs), pur-
chased from Lonza (CC-2519, Lonza Group Ltd, Switzerland),
were cultured on gelatine-coated dishes in M199 medium (Sigma)
supplemented with 10% FCS, 10 mg/ml heparin, endothelial cell
growth supplement (ECGS, Sigma), glutamine and antibiotics.
Each culture was used only up to eight population doublings.
For transient transfection of HEK293 cells to be used in GST-
pull down and co-IP experiments, cells were plated one day before
transfection and grown to semiconfluence. Transfections were
carried out using the calcium-phosphate method and assays were
performed 36 h after transfection.
COS-7 and A7r5 cells to be used for fluorescence microscopy
analysis were transiently transfected with EGFP-KRIT1A and
Flag-Nd1-L cDNAs using FuGENE 6 (Roche) and TransITH-
2020 (Mirus) transfection reagents, respectively, according to the
manufacturers’ instructions. The same method was used to
transiently transfect K2/2 and K9/6 MEF cells [9] with Flag-
Nd1-L cDNA for Western blotting analyses.
Fluorescence microscopy
48 h after transfection, COS-7 or A7r5 cells were fixed in 3,7%
paraformaldehyde for 15 min. Cells expressing Flag-Nd1-L were
than permeabilized with 0.5% Triton X-100 in TBS for 1 min,
incubated with 1% BSA in TBS for 1 h, and stained with anti-Flag
epitope primary antibody (F3165, Sigma) and Alexa FluorH 633
(Invitrogen) secondary antibodies. All transfected cells were then
counterstained with a blue fluorescent nuclear dye (Hoechst
34580) and mounted on microscope slides with ProLongH Gold
antifade reagent (Molecular Probes, Invitrogen) before imaging.
Confocal microscopy imaging was performed on a Leica
TCS_SP5 confocal microscope (Leica Microsystems) using a
PlanApo 63x/1.40 oil immersion objective. Instrument parame-
ters for sequential image acquisition, including pinhole diameter,
laser intensity, exposure time, PMT gain and offset, were set and
held constant to minimize autofluorescence and for comparison
between samples. Colocalization images were obtained using the
ImageJ software.
Cell lysates
To prepare cell lysates, transfected or mock-transfected
HEK293, HUVEC or MEF cells in 90 mm plates were washed
with ice-cold PBS, scraped in the presence of NP-40 lysis buffer
containing protease inhibitors (KIT Complete, Roche), collected
in a clean tube and finally incubated on ice for 20 min. The cell
lysates were centrifuged for 10 min at 150006g and the
supernatant was collected in a clean tube for further analysis.
GST-Pull-down experiments
GST fusion proteins (40 mg) immobilized on 40 ml of glutathi-
one-sepharose 4B beads (50% in PBS) were incubated for 1 h at
room temperature with of HEK293 cells lysates overexpressing the
GFP- or 2FLAG-tagged target proteins. The beads were
subsequently washed three times with PBS buffer, added with
SDS gel-loading buffer and finally analyzed by SDS-PAGE
followed by anti-GFP (Sigma) or anti-FLAG (Sigma) western
blotting.
Co-immunoprecipitation (co-IP) experiments
For co-IP of endogenous proteins (KRIT1 and Nd1-L) HUVEC
cell lysates were prepared as described and then pre-cleared by
adding 20 ml of Protein A/agarose Fast-flow (Sigma) (50%) per
500 mg of cell lysate and incubated at 4uC for 1 h in an orbital
shaker. The protein A was removed by centrifugation and the
supernatant was incubated overnight at 4uC with a polyclonal anti-
KRIT1 antibody produced in our laboratory. In order to capture
the immunocomplex, 30 ml of ProteinA/agarose (50%) were added
to the incubation mix and incubated at 4uC for 4 h. The agarose
slurry was collected by centrifugation and the supernatant was
discarded; the pellet was washed three times with NP-40 lysis buffer,
then resuspended in SDS gel-loading buffer and analyzed by SDS-
PAGE followed by anti-Nd1-L (Sigma) western blotting.
For co-IP of overexpressed proteins, lysates from HEK293 cells
co-transfected with the expression vectors encoding EGFP-tagged
KRIT1A or KRIT1B and 2FLAG-Nd1-L were used. The co-
immunoprecipation was performed as above by using anti-KRIT1
to precipitate the immunocomplex and anti-FLAG to perform
western blotting analysis.
Western blotting
Western blotting analyses were performed by using the Snap i.d.
Protein Detection System (Millipore, WBAV DBA SE). Briefly, the
different samples were separated by SDS-PAGE and electro-
transferred onto nitrocellulose membranes. The blots were then
assembled in the blot holder and treated according to the
manufacturer’s instructions using distinct primary antibodies,
including mouse mAbs against SOD2 (16956, Abcam) and
Tubulin (T5168, Sigma). Primary antibodies were detected using
affinity purified HRP-conjugated secondary antibodies (Sigma).
Immunoreactive proteins were finally visualized by an enhanced
chemioluminescence (ECL) detection system (GE Healthcare).
The results showed in the Figures are representative of at least
three independent experiments.
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